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Background: The authors used the lipid index (WL) to monitor lipid changes before and after surgery. The surgical
operation performed was the simultaneous enucleation of a cystic tumor of the hilum ovarii in its entirety (with
diagnosis of a simple cyst or teratoma adultum) in groups of 20 patients.
Objectives: To compare the lipid index WL in the blood serum of patients undergoing surgery treatment at the
following times: before and 7 days after surgery, and 6 and 12 months after surgery.
Material and methods: The research material was the blood serum of women aged about 24 years. The authors
divided the patients into 3 groups: two groups of 20 women and a control group. The concentrations of the lipid
parameters were measured and the lipid index WL was calculated.
Results: Statistically significant differences were found between the lipid index of serum from patients with
diagnosed ovarian neoplasms and the index of serum from healthy subjects; differences were demonstrated in the
postoperative period, particularly 6 and 12 months after surgery.
Conclusions: The lipid index WL proved useful in diagnosing ovarian neoplasm (simple cysts and teratoma
adultum) and in monitoring the postoperative period.
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Since 2002, the lipid index has been successfully used in
oncogynecological diagnostics. The index is calculated
using the concentrations of HDL and LDL lipoprotein,
apolipoprotein A1 and B, and triglycerides (TG) [1,2].
The usefulness of this marker has been demonstrated in
monitoring changes in lipid metabolism in perimenopausal
women undergoing gynecological surgery, as well as in the
assessment of hormone replacement therapy [3-5].
Based on these results, it was decided that the objec-
tive of the present study would be to determine the diag-
nostic role of this indicator in the blood serum of* Correspondence: piotr.rubisz@gmail.com
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article, unless otherwise stated.women undergoing surgery due to neoplastic hyperplasia
within the ovary and parovarian mesonephritic struc-
tures. These procedures were performed due to a diag-
nosis of teratoma: adultum teratoma [6-8] or a simple
cyst [9-11].
The motivation to undertake this research lies in the
fact that the authors have found no comprehensive pub-
lication in the available literature describing the lipid
index in gynecological oncology.Material and methods
The study included three groups of women, each of up
to 20 people.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Lipid index WL in blood serum in the study
groups
Lipid index WL
Group I 9.99 ± 0.85
Group II
(simple cyst)
A. Before surgery 3.16 ± 0.41
B. 7 days after surgery 3.19 ± 0.40
C. 6 months after surgery 4.41 ± 0.60
D. 12 months after surgery 5.25 ± 0.35
Group III
(teratoma adultum)
A. Before surgery 5.94 ± 0.44
B. 7 days after surgery 5.98 ± 0.48
C. 6 months after surgery 6.40 ± 0.46
D. 12 months after surgery 8.51 ± 0.69
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of 24.3 years. The criteria for inclusion in Group I were
as follows:
 no pathological findings in gynecological
examination;
 normal values of urine analyses, blood counts, and
diagnostic enzymology;
 age between 18 and 28 years; and
 BMI between 19.5 and 26 kg/m2.
The exclusion criterion was a history of liver, kidney,
or bile-duct disease.
Patients in Group II were operated on because of
neoplastic lesions within the ovarian and parova-
rian structures (appendages). Histopathological exami-
nation showed benign hyperplasia of the simple cyst
type was found. The following are the criteria for in-
clusion into the group:
 age between 18 and 28 years;
 tumor size between 5 and 22 cm, as determined
by means of gynecological examination and
confirmed by ultrasound examination;
 histopathological diagnosis.
The patients in Group III were operated on because of
neoplastic lesions within the appendages (ovary, pa-
roophoron, epoophoron, or other mesonephritic struc-
tures). Postoperative histopathological examination
revealed a mature teratoma. The indication for surgery
in both Groups II and III was tumor size of 5–20 cm in
diameter, determined by means of gynecological exam-
ination and confirmed by ultrasound examination.
The range of performed operations included enucle-
ation of the cyst in one piece, preserving oncological
asepsis and followed by intraoperative pathology
consultation.
Biochemical measurements were performed prior to
surgery (A), 7 days after surgery (B), and 6 and
12 months after surgery (C and D, respectively).
The research material was blood taken from the
basilic vein. The samples obtained from blood serum
were analyzed by assessing the concentration of:
 apolipoprotein A and B using immunoturbidimetric
method with the Orion Diagnostica reagent on a
Technicon RA 1000 (USA) analyzer;
 triglycerides (TG) using the enzymatic
colorimetric method;
 lipoprotein HDL cholesterol by precipitation;
and
 total cholesterol (TCH) using the enzymatic
oxidase method.The lipoprotein LDL cholesterol level was calculated
using the Friedewald formula.
Given the lipid metabolism parameters, the lipid index
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LDLþ TG5
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The obtained results are presented as arithmetic
means and standard deviations, which were statistically
analyzed using Student’s t-test and adjusted with the
Bonferroni correction, whose significance level for the
studied index was 0.05/5 = 0.01.
The study was performed and financed under grant
No. 500/03 from Wrocław Medical University, Poland.
Results
Table 1 presents the data on the lipid index WL in the
blood serum from the test groups. The results of the
statistical analysis are shown in Table 2. It is clear from
the data that there was a statistically significant decrease
in this parameter in both Groups II and III, compared to
the control Group I (p < 0.001). After surgery, Groups II
and III showed the highest statistically significant differ-
ences between times A and D (p < 0.001). Other results
for these two groups between the different time points
were highly significant (p < 0.01 and p < 0.001), except
for time points A and B, that is, before and 7 days after
surgery.
The relationship of the percentage of this parameter in
both groups compared with the control group is pre-
sented in Figure 1. Before the surgery, both groups had
lower lipid indices WL, at approximately 31% for Group
II and 60% for Group III. After the procedure, a constant
upward trend was observed in this parameter, and the
data at time D are about 52% for Group II and about
85% for Group III.
Table 2 Statistical analysis
Groups P value
I: II A 0.001
I: III A 0.001
II A: II B NS
II A: II C 0.001
II A: II D 0.001
II B: II C 0.001
II B: II D 0.001
II C : II D 0.001
III A: III B NS
III A: III C 0.01
III A: III D 0.001
III B: III C 0.01
III B: III D 0.001
III C: III D 0.001
Karmowski et al. Journal of Ovarian Research 2014, 7:90 Page 3 of 4
http://www.ovarianresearch.com/content/7/1/90Discussion
Previous studies using the lipid index WL have shown
its usefulness in monitoring hormone replacement
therapy in postmenopausal women.
In the search for useful diagnostic indicators in
gynecological oncology, a slight deviation from the norm
of lipid parameters was found. However, the applicationFigure 1 Lipid index (%) in each group of patients compared with theof the lipid index WL, which is calculated from HDL,
LDL, TG, ApoA1, and ApoB, showed a decrease in
this parameter of up to 30% in the serum of patients,
as compared with healthy subjects. Further studies
have shown differences that depend on the type of
gynecological disease.
This information encouraged the authors to conduct
further diagnostic tests and monitoring over the
12 months after the operations. Results that are par-
ticularly interesting include those for times C and D,
where there was an increase in the lipid index WL,
slowly reaching the values characteristic of healthy
women of similar age and BMI. After one year, indi-
ces of growth of about 25% for teratoma adultum and
about 20% for simple cysts was found, which corre-
lates with the clinical evaluation of the patients.
It appears that further clinical trials on this in-
dicator which also take into account data regarding
physical activity, diet, and risk factors for diseases of
civilization will allow for the development of a heal-
thy control system based on the observation of lipid
metabolism in women.Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.control group.
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